Page last updated: 2024-10-24

bupivacaine and Cytomegalic Inclusion Disease

bupivacaine has been researched along with Cytomegalic Inclusion Disease in 2 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
James, CM1
Bartlett, EJ1
Mansfield, JP1
Cull, VS1
Endrész, V1
Burián, K1
Berencsi, K1
Gyulai, Z1
Kari, L1
Horton, H1
Virok, D1
Méric, C1
Plotkin, SA1
Gönczöl, E1

Other Studies

2 other studies available for bupivacaine and Cytomegalic Inclusion Disease

ArticleYear
Interferon subtype gene therapy for regulating cytomegalovirus disease.
    Methods in molecular medicine, 2005, Volume: 116

    Topics: Anesthetics, Local; Animals; Bupivacaine; Cytomegalovirus Infections; Gene Transfer Techniques; Gene

2005
Optimization of DNA immunization against human cytomegalovirus.
    Vaccine, 2001, Jul-16, Volume: 19, Issue:28-29

    Topics: Animals; Antibodies, Viral; Antigens, Viral; Bupivacaine; Cytomegalovirus; Cytomegalovirus Infection

2001